Developers of promising medical technologies could get a boost from the NIH under a “Shark Tank"-like program the agency’s director wants to keep once the pandemic subsides.
The initiative, called RADx, responded to Covid-19 testing shortfalls last spring by setting up a venture capital like fund within the National Institutes of Health that focused on the most promising technologies. RADx is one of several initiatives created in response to Covid-19 that NIH Director Francis S. Collins said Wednesday he’s likely to keep to mobilize more quickly instead of reverting to the old ways of doing business.
The Covid-19 crisis ...